Volume 6 Supplement 1
Proceedings of the 2011 International Conference on Bioinformatics and Computational Biology (BIOCOMP'11)
Detecting differentially methylated loci for Illumina Array methylation data based on human ovarian cancer data
- Zhongxue Chen^{1}Email author,
- Hanwen Huang^{2},
- Jianzhong Liu^{3},
- Hon Keung Tony Ng^{4},
- Saralees Nadarajah^{5},
- Xudong Huang^{6} and
- Youping Deng^{7}
DOI: 10.1186/1755-8794-6-S1-S9
© Chen et al.; licensee BioMed Central Ltd. 2013
Published: 23 January 2013
Abstract
Background
It is well known that DNA methylation, as an epigenetic factor, has an important effect on gene expression and disease development. Detecting differentially methylated loci under different conditions, such as cancer types or treatments, is of great interest in current research as it is important in cancer diagnosis and classification. However, inappropriate testing approaches can result in large false positives and/or false negatives. Appropriate and powerful statistical methods are desirable but very limited in the literature.
Results
In this paper, we propose a nonparametric method to detect differentially methylated loci under multiple conditions for Illumina Array Methylation data. We compare the new method with other methods using simulated and real data. Our study shows that the proposed one outperforms other methods considered in this paper.
Conclusions
Due to the unique feature of the Illumina Array Methylation data, commonly used statistical tests will lose power or give misleading results. Therefore, appropriate statistical methods are crucial for this type of data. Powerful statistical approaches remain to be developed.
Availability
R codes are available upon request.
Background
It is well known that DNA methylation has important effects on transcriptional regulation, chromosomal stability, genomic imprinting, and X-inactivation [1, 2]. It has been also shown to be associated with many human diseases, such as various types of cancer [3–11].
With the advances of BeadArray technology, genome-wide high-throughput methylation data can be easily generated by Illumina GoldenGate and Infinium Methylation Assays. After preprocessing steps, such as background correction and normalization, are applied to the raw fluorescent intensities, for each locus, from about 30 replicates in the same array a summarized β-value is generated as follows: $\frac{\text{max}\left\{M,0\right\}}{\text{max}\left\{M,0\right\}+\text{max}\left\{U,0\right\}+100}$, where M is the average signal from a methylated allele while U is that from unmethylated allele. The β -values are continuous numbers between 0 and 1, with 0 stands for totally unmethylated and 1 for completely methylated.
It has been shown that the β -value is rarely normally distributed [9, 12, 13]. Therefore the commonly used t-test for case control designs or ANOVA for multiple conditions are not the most powerful approaches when detecting differentially methylated loci. Observing this, Wang has proposed a model-based likelihood ratio test to detect differentially methylated loci for case and control data under the assumption that the β -value follows a three-component normal-uniform distribution [9]. Wang showed that for some situations, their proposed test was better than the simple t-test based on simulation studies.
However, in their method, Wang did not consider the effect of age, which has been shown highly associated with methylation [14, 15]. Noticing the importance of age effect, one may use a linear regression with age included as a covariate when analyze methylation data with multiple conditions, such as cancer types. However, the underlying assumption of equal variances may not be satisfied [12]. Therefore the commonly used linear regression method may not be appropriate.
In this paper, we consider methylation data with multiple conditions and propose a nonparametric method which incorporates the age effect in a way through the idea of combining p-values from independent tests [12, 16, 17]. More specifically, we first group subjects into several age groups based on their age; then for each age group, a nonparametric Kruskal-Wallis test is conducted for the given locus and the p-value is recorded. An overall p-value for that locus will be estimated through combining the p-values from all age groups. Using a real methylation data with three conditions and a simulation study, we show that the proposed test is more powerful than other methods, including linear regression.
Method
Proposed method
Combined ANOVA test
Combined median test
Another nonparametric test is median test using the following statistic for each age group:
Combined welch test
where ${w}_{k}={n}_{k}/{s}_{k}^{2},\widehat{\mu}\text{=}{\displaystyle \sum _{k=1}^{K}}{w}_{k}{\stackrel{\u0304}{x}}_{k}/w,\text{w=}\sum _{k=1}^{K}{w}_{k},{\text{h}}_{k}=\left(1-{w}_{k}/{w}^{2}\right)/\left({n}_{k}-1\right)$.
Methods for combining p-values
Besides the Fisher method mentioned above, we also consider Z-test to combine p-values from independent tests. First we calculated the weighted Z statistic using individual p-values from each age group: $Z={\displaystyle \sum _{g=1}^{G}}{n}_{g}{\Phi}^{-1}\left(1-{p}_{g}\right)/{\displaystyle \sum _{g=1}^{G}}{n}_{g}^{2}$, where n_{ g } is the total sample size in age group g and Φ is the cumulative distribution function (CDF) of the standard normal distribution. It is easy to see that this statistic has standard normal distribution under the null hypothesis. The overall p-value is calculated by 1- Φ(Z). Note that here we use one-sided test to obtain the overall p-value.
Simulation settings
Estimated type I error rates at significance level 0.05 with 10000 replicates.
Distribution (sample sizes, parameters) | ANOVA | median | Welch | KW |
---|---|---|---|---|
Beta (s = 30,30,30, a = 1,1,1, b = 2,2,2) | 0.048 | 0.040 | 0.052 | 0.047 |
Beta (s = 30,30,30, a = 1,1,1, b = 10,10,10) | 0.052 | 0.044 | 0.053 | 0.051 |
Beta (s = 30,30,30, a = 10,10,10, b = 1,1,1) | 0.047 | 0.044 | 0.052 | 0.048 |
Beta (s = 30,30,30, a = 10,10,10, b = 10,10,10) | 0.045 | 0.045 | 0.047 | 0.046 |
Beta (s = 20,30,40, a = 1,1,1, b = 2,2,2) | 0.053 | 0.052 | 0.050 | 0.053 |
Beta (s = 20,30,40, a = 1,1,1, b = 10,10,10) | 0.049 | 0.049 | 0.054 | 0.048 |
Beta (s = 20,30,40, a = 10,10,10, b = 1,1,1) | 0.045 | 0.049 | 0.056 | 0.044 |
Beta (s = 20,30,40, a = 10,10,10, b = 10,10,10) | 0.050 | 0.051 | 0.043 | 0.052 |
TN (s = 30,30,30, μ = 0.5,0.5, 0.5, σ^{2} = 0.1,0.1,0.1) | 0.050 | 0.044 | 0.053 | 0.045 |
TN(s = 30,30,30, μ = 0.5, 0.5, 0.5, σ^{2} = 0.1,0.2,0.3) | 0.053 | 0.067 | 0.047 | 0.053 |
TN (s = 20,30,40, μ = 0.5, 0.5, 0.5, σ^{2} = 0.1,0.1,0.1) | 0.050 | 0.052 | 0.052 | 0.049 |
TN(s = 20,30,40, μ = 0.5, 0.5, 0.5, σ^{2} = 0.1,0.2,0.3) | 0.047 | 0.054 | 0.051 | 0.043 |
Empirical power at significance level 0.05 with 10000 replicates.
Distribution (sample sizes, parameters) | ANOVA | median | Welch | KW |
---|---|---|---|---|
Beta (s = 30, 30,30, a = 5,5,5,b = 20,25,30 | 0.821 | 0.576 | 0.810 | 0.775 |
Beta(s = 30, 30,30, a = 1.5,2,2.5, b = 20,20,20 | 0.650 | 0.504 | 0.648 | 0.710 |
Beta (s = 30, 30,30, a = 20,20,20, b = 1.5,2,2.5, | 0.658 | 0.495 | 0.656 | 0.713 |
Beta (s = 20,30,40, a = 5,5,5, b = 20,25,30) | 0.792 | 0.546 | 0.740 | 0.735 |
Beta (s = 20,30,40, a = 1.5,2,2.5, b = 20,20,20) | 0.599 | 0.479 | 0.634 | 0.670 |
Beta (s = 20,30,40, a = 20,20,20, b = 1.5,2,2.5) | 0.607 | 0.475 | 0.637 | 0.665 |
TN (s = 30, 30,30, μ = 0.45,0.5,0.55, σ^{2} = 0.2) | 0.383 | 0.240 | 0.378 | 0.362 |
TN (s = 30, 30,30, μ = 0.45,0.5,0.55, σ^{2} = 0.1,0.2,0.3) | 0.338 | 0.325 | 0.412 | 0.341 |
TN (s = 20,30,40, μ = 0.45,0.5,0.55, σ^{2} = 0.2) | 0.349 | 0.238 | 0.343 | 0.328 |
TN (s = 20,30,40, μ = 0.45,0.5,0.55, σ^{2} = 0.1,0.2,0.3) | 0.219 | 0.361 | 0.423 | 0.259 |
A real data set
We will use a real methylation data set, the United Kingdom Ovarian Cancer Population Study (UKOPS) [15] with 274 controls, 131 pre-treatment cases, and 135 post treatment cases, to compare the performance of the proposed test with others. Those methylation data were generated by the Illumina Infinium Huamn Methylaytion27 BeadChip and can be downloaded under accession number GSE19711 from the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo).
Number of samples in age group by treatment group used in the paper after removing subjects with bs <4000 or coverage rate <95% or age >80.
Age group | control | Pre-treat | Post-treat | Total |
---|---|---|---|---|
50_55 | 14 | 15 | 16 | 45 |
55_60 | 61 | 17 | 25 | 103 |
60_65 | 64 | 17 | 22 | 103 |
65_70 | 35 | 17 | 21 | 73 |
70_75 | 63 | 24 | 22 | 109 |
75_over | 20 | 18 | 9 | 47 |
Total | 257 | 108 | 115 | 480 |
Results
Simulation results
Table 1 reports the estimated type I error rates from each method under different conditions. For most of the time, the estimated type I error rates are close to the nominal significance level as expected. Table 2 gives the empirical powers from each method. It can be seen that the non-parametric method of Mood's median test usually has the lowest powers in the simulations. None of the ANOVA, Welch and KW tests is uniformly most powerful. In words, their performances depend on the distributions from which the data are generated. From our simulation study, the KW test is usually as powerful as or more powerful than the ANOVA test. The true distributions of the β -value may vary from locus to locus; it is impossible to simulate all possible distributions. However, based on the observation of the real data, we know that the distributions of the β -value are far from the normal distribution, under which ANOVA is the best test. Therefore, we prefer nonparametric tests which are more robust.
Results from real data set
Number of significant differentially methylated loci detected for given cutoff p-value based on the real data.
Method | 1e-3 | 1e-4 | 1e-5 | 1e-6 | ||||
---|---|---|---|---|---|---|---|---|
Fisher | Z-test | Fisher | Z-test | Fisher | Z-test | Fisher | Z-test | |
ANOVA | 981 | 1079 | 655 | 690 | 479 | 499 | 350 | 375 |
Median | 906 | 893 | 464 | 449 | 255 | 240 | 143 | 127 |
Welch | 1096 | 1106 | 640 | 673 | 416 | 424 | 281 | 289 |
K-W | 1359 | 1340 | 823 | 859 | 551 | 590 | 381 | 401 |
Discussion and conclusions
Due to the unique feature of the β -value of methylation data, traditional statistical methods, such as linear regression and ANOVA test may not be appropriate. It has been shown that methylation is highly correlated with age; ignoring age effect may cause many false positives and/or false negatives. The effect of age may also not be linear; therefore we need a better way to account for this effect. In this paper, we use p-value combination method to deal with age effect. For each age group, we use nonparametric method to compare the treatment groups. It is important to find powerful and robust nonparametric methods for this sort of data. Although we found that KW method is more powerful than some other nonparametric methods for methylation data, it is desirable to find more powerful tests in this area. Furthermore, we want to point out that there are many other methods can be used to combine p-values [22, 23]; it may also be possible to find a more powerful method to combine p-values for Illumina Array Methylation data. However, based on our experiences, Fisher test is more robust and can be used in situations when a small portion of the p-values are very small; while the Z test is more powerful when the effect sizes are similar (e.g., the p-values don't differ much) for all of the age groups. Finally, although in this paper we use different cutoff p-values to compare the performance of tests, one may want to control the false positive rate. Several multiple comparison methods have been proposed for large scale data set to deal with the situations where the variables (loci) are not independent [24–28]. However, it remains to study which approach is more appropriate for the methylation data.
Declarations
Acknowledgements
This article has been published as part of BMC Medical Genomics Volume 6 Supplement 1, 2013: Proceedings of the 2011 International Conference on Bioinformatics and Computational Biology (BIOCOMP'11). The full contents of the supplement are available online at http://www.biomedcentral.com/bmcmedgenomics/supplements/6/S1. Publication of this supplement has been supported by the International Society of Intelligent Biological Medicine.
Authors’ Affiliations
References
- Kuan PF, Wang S, Zhou X, Chu H: A statistical framework for Illumina DNA methylation arrays. Bioinformatics. 2010, 26 (22): 2849-10.1093/bioinformatics/btq553.PubMed CentralView ArticlePubMedGoogle Scholar
- Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Gräf S, Tomazou EM, Bäckdahl L, Johnson N, Herberth M: An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome research. 2008, 18 (9): 1518-1529. 10.1101/gr.077479.108.PubMed CentralView ArticlePubMedGoogle Scholar
- Baylin SB, Ohm JE: Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction?. Nature Reviews Cancer. 2006, 6 (2): 107-116. 10.1038/nrc1799.View ArticlePubMedGoogle Scholar
- Feinberg AP, Tycko B: The history of cancer epigenetics. Nature Reviews Cancer. 2004, 4 (2): 143-153. 10.1038/nrc1279.View ArticlePubMedGoogle Scholar
- Jabbari K, Bernardi G: Cytosine methylation and CpG, TpG (CpA) and TpA frequencies. Gene. 2004, 333: 143-149.View ArticlePubMedGoogle Scholar
- Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nature Reviews Genetics. 2002, 3 (6): 415-428.PubMedGoogle Scholar
- Kulis M, Esteller M: DNA methylation and cancer. Adv Genet. 2010, 70: 27-56.View ArticlePubMedGoogle Scholar
- Laird PW: Principles and challenges of genome-wide DNA methylation analysis. Nature Reviews Genetics. 2010, 11 (3): 191-203.View ArticlePubMedGoogle Scholar
- Wang S: Method to detect differentially methylated loci with case-control designs using Illumina arrays. Genetic Epidemiology. 2011, 35 (December): 686-694.PubMed CentralView ArticlePubMedGoogle Scholar
- Xu GL, Bestor TH, Bourc'his D, Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, Viegas-Péquignot E: Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature. 1999, 402 (6758): 187-191. 10.1038/46052.View ArticlePubMedGoogle Scholar
- Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D: Increased methylation variation in epigenetic domains across cancer types. Nature Genetics. 2011, 43 (8): 768-775. 10.1038/ng.865.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen Z, Liu Q, Nadarajah S: A new statistical approach to detecting differentially methylated loci for case control Illumina array methylation data. Bioinformatics. 2012, 28 (8): 1109-1113. 10.1093/bioinformatics/bts093.PubMed CentralView ArticlePubMedGoogle Scholar
- Huang H, Chen Z: Age adjusted nonparametric detection of differential DNA methylation with case-control designs. Unpublished manuscript.
- Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Padbury JF, Bueno R: Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS genetics. 2009, 5 (8): e1000602-10.1371/journal.pgen.1000602.PubMed CentralView ArticlePubMedGoogle Scholar
- Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H, Campan M, Noushmehr H, Bell CG, Maxwell AP: Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome research. 2010, 20 (4): 440-446. 10.1101/gr.103606.109.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen Z, Ng HKT: A robust method for testing association in genome-wide association studies. Human Heredity. 2012, 73 (1): 26-34. 10.1159/000334719.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen Z: A new association test based on Chi-square partition for case-control GWA studies. Genetic Epidemiology. 2011, 658-658. 35
- Fisher RA: Statistical methods for research workers. Edinburgh: Oliver and Boyd. 1932Google Scholar
- Welch B: On the comparison of several mean values: An alternative approach. Biometrika. 1951, 38 (3/4): 330-336. 10.2307/2332579.View ArticleGoogle Scholar
- Cochran WG: Problems arising in the analysis of a series of similar experiments. Journal of Royal Statistical Society, Series C: Applied Statistics. 1937, 4: 102-118.Google Scholar
- Chen Z, Ng HKT, Nadarajah S: A note on Cochran test for homogeneity in one-way ANOVA and meta-analysis. Statistical Papers. 2012, 1-10.Google Scholar
- Chen Z: Is the weighted z-test the best method for combining probabilities from independent tests?. Journal of Evolutionary Biology. 2011, 24 (4): 926-930. 10.1111/j.1420-9101.2010.02226.x.View ArticlePubMedGoogle Scholar
- Chen Z, Nadarajah S: Comments on 'Choosing an optimal method to combine p-values' by Sungho Won, Nathan Morris, Qing Lu and Robert C. Elston, Statistics in Medicine 2009; 28: 1537-1553. Statistics in Medicine. 2011, 30 (24): 2959-2961. 10.1002/sim.4222.View ArticlePubMedGoogle Scholar
- Dudbridge F, Gusnanto A: Estimation of significance thresholds for genomewide association scans. Genet Epidemiol. 2008, 32 (3): 227-234. 10.1002/gepi.20297.PubMed CentralView ArticlePubMedGoogle Scholar
- Gao X, Starmer J, Martin ER: A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol. 2008, 32 (4): 361-369. 10.1002/gepi.20310.View ArticlePubMedGoogle Scholar
- Moskvina V, Schmidt KM: On multiple-testing correction in genome-wide association studies. Genet Epidemiol. 2008, 32 (6): 567-573. 10.1002/gepi.20331.View ArticlePubMedGoogle Scholar
- Pe'er I, Yelensky R, Altshuler D, Daly MJ: Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol. 2008, 32 (4): 381-385. 10.1002/gepi.20303.View ArticlePubMedGoogle Scholar
- Chen Z, Liu Q: A new approach to account for the correlations among single nucleotide polymorphisms in genome-wide association studies. Human Heredity. 2011, 72 (1): 1-9. 10.1159/000330135.PubMed CentralView ArticlePubMedGoogle Scholar
Copyright
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.